Cannabis PolandWAR:CBD -1.06%24 Days Payable is 884.54 as of Mar. 2026, which is 39% above its 10-year median of 637.38. GuruFocus rates WAR:CBD with a GF Score™ of 24/100. The stock has 7 warning signs investors should review. Among 922 Drug Manufacturers companies, Cannabis Poland ranks better than 96.31% on this metric.
The historical rank and industry rank for Cannabis Poland's Days Payable or its related term are showing as below:
WAR:CBD'
s Days Payable Range Over the Past 10 Years
Min: 113.35 Med: 637.38 Max: 43617.5
Current: 785.44
During the past 13 years, Cannabis Poland's highest Days Payable was 43617.50. The lowest was 113.35. And the median was 637.38.
WAR:CBD's Days Payable is ranked better than 96.31% of 922
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs WAR:CBD: 785.44
Cannabis Poland's Days Payable
declined
from Mar. 2025 (1,862.33) to Mar. 2026 (884.54).
It may suggest that Cannabis Polandaccelerated paying its suppliers.
Cannabis Poland Days Payable Related Terms
Cannabis Poland Days Payable Historical Data
* Premium members only.
The historical data trend for Cannabis Poland's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:CBD vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Poland's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabis Poland Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cannabis Poland's Days Payable distribution charts can be found below:
* The bar in red indicates where Cannabis Poland's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Cannabis Poland's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabis Poland (WAR:CBD) has a Days Payable of 884.54 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cannabis Poland and its competitors. This is 39% above median its historical median of 637.38. Over the past decade, Cannabis Poland's Days Payable has ranged from 113.35 to 43,617.50. According to the industry distribution chart, Cannabis Poland ranks #34 out of 922 companies in the Drug Manufacturers industry, placing it in the top 3.7%.
Is Cannabis Poland's Days Payable too high?
Cannabis Poland's current Days Payable of 884.54 is 39% above median its 10-year median of 637.38. Over the past 10 years, this metric has ranged from a low of 113.35 to a high of 43,617.50. The Drug Manufacturers industry median Days Payable is 90.84. Cannabis Poland's value of 884.54 is 873.8% above this industry median. Based on the distribution chart, Cannabis Poland ranks #34 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Cannabis Poland has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Cannabis Poland's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cannabis Poland ranks #34 out of 922 companies for Days Payable. This places Cannabis Poland in the top 4% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.84. Cannabis Poland's value of 884.54 is 873.8% above this benchmark. Historically, Cannabis Poland's own Days Payable has ranged from 113.35 to 43,617.50 over the past decade. While the company's 10-year median is 637.38 vs. the industry median of 90.84, Cannabis Poland has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannabis Poland's current Days Payable of 884.54 is 873.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cannabis Poland and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabis Poland's current Days Payable is 884.54, which is 39% above median its own 10-year median of 637.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Poland stock overvalued right now?
Cannabis Poland (WAR:CBD) has a current Days Payable of 884.54. The current Days Payable is 884.54, which is 39% above median its 10-year median of 637.38 and 873.8% above the Drug Manufacturers industry median of 90.84. Cannabis Poland's overall GF Score™ is 24/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cannabis Poland (WAR:CBD), the current Days Payable is 884.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:CBD has been successfully added to your 
